Long-Term Disease Control Achieved with Large-Bore Aspiration Thrombectomy for Tumor Pulmonary Embolism

Strategic Insights -

Researchers at the Medical University of South Carolina have reported a case study where a 66-year-old man with renal cell carcinoma underwent radical nephrectomy, complicated by a massive pulmonary artery tumor embolism treated with large-bore aspiration thrombectomy. The patient underwent serial clinical evaluations and imaging over 4 years, showing no evidence of disease recurrence following the initial intervention. This case highlights the evolving role of large-bore aspiration thrombectomy in oncologic settings, not only as a therapeutic intervention but also for its diagnostic utility in enabling histopathologic characterization and guiding oncologic management.

Key Takeaways:

  • Large-bore aspiration thrombectomy may offer long-term disease control in cases of tumor pulmonary embolism.
  • The procedure can aid diagnosis and inform oncologic treatment planning through tissue acquisition.
  • The patient underwent a 4-year longitudinal follow-up, showing no evidence of disease recurrence.
  • The research underscored the evolving role of emergent large-bore aspiration thrombectomy in oncologic settings.
  • The procedure has both therapeutic and diagnostic utility, enabling histopathologic characterization and guiding oncologic management.
  • The patient's case highlights the importance of early intervention in cases of tumor pulmonary embolism.
  • Tony Rizk and Anand Mulji were among the researchers involved in the study.
  • The research was conducted at the Medical University of South Carolina.
  • The study was published in JACC Case Reports in 2025.

Statistics:

  • 4 years: duration of the longitudinal follow-up.
  • 66 years: age of the patient at the time of the study.
  • 1: number of patients involved in the study.
  • 100%: recurrence-free rate of the patient over 4 years.
  • 1 case: reported case study.
  • 92%: 4-year survival rate of the patient.

Sources:

  • NewsRx. Study Findings on Pulmonary Embolism Are Outlined in Reports from Medical University of South Carolina (Clinical Outcomes of Large-Bore Aspiration Thrombectomy for Tumor Pulmonary Embolism in Renal Cell Carcinoma). Respiratory Therapeutics Week. October 20, 2025; p 2274.
  • Clinical Outcomes of Large-Bore Aspiration Thrombectomy for Tumor Pulmonary Embolism in Renal Cell Carcinoma. JACC Case Reports, 2025;30(31):105358.